Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung

Clinical Cancer Research

Volumn 4, Issue 9, 1998, Pages 2279-2289

  Wright, Scott R ^a   Boag, Alexander H ^a   Valdimarsson, Gunnar ^a   Hipfner, David R ^a   Campling, Barbara G ^a   Cole, Susan P C ^a   Deeley, Roger G ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; BRONCHUS MUCOSA; CANCER CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ALVEOLUS CELL TYPE 1; LUNG ALVEOLUS CELL TYPE 2; LUNG CANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

AGED; ANTIBODIES, MONOCLONAL; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM STAGING; TUMOR CELLS, CULTURED;

EID: 0031694229     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Schottenfeld, D. Epidemiology of lung cancer. In: H. I. Pass, J. B. Mitchell, D. H. Johnson, and A. T. Turrisi (eds.), Lung Cancer: Principles and Practice, pp. 305-321. Philadelphia: Lippincott-Raven, 1996.
2. Cole, S. P. C. Multidrug resistance in human lung cancer and topoisomerase II. In: H. I. Pass, J. B. Mitchell, D. H. Johnson, and A. T. Turrisi (eds.), Lung Cancer: Principles and Practice, pp. 169-204. Philadelphia: J. B. Lippincott, 1996.
3. Gottesman, M. M., Pastan, I., and Ambudkar, S. V. P-glycoprotein and multidrug resistance. Curr. Biol., 6: 610-617, 1996.
4. Deeley, R. G., and Cole, S. P. C. Function, evolution and structure of multidrug resistance protein (MRP). Semin. Cancer Biol., 8: 193-204, 1997.
5. Lautier, D., Canitrot, Y., Deeley, R. G., and Cole, S. P. C. Multidrug resistance mediated by the Multidrug Resistance Protein (MRP) gene. Biochem. Pharmacol., 52: 967-977, 1996.
6. Lai, S-L., Goldstein, L. J., Gottesman, M. M., Pastan, I., Tsai, C-M., Johnson, B. E., Mulshine, J. L., Ihde, D. C., Kayser, K., and Gazdar, A. F. MDR1 gene expression in lung cancer. J. Natl. Cancer Inst., 81: 1144-1150, 1989.
7. Shin, H. J. C., Lee, J. S., Hong, W. K., and Shin, D. M. Study of multidrug resistance (mdr1) gene in non-small-cell lung cancer. Anticancer Res., 12: 367-370, 1992.
8. Goldstein, L. J. MDR1 gene expression in solid tumours. Eur. J. Cancer, 32A: 1039-1050, 1996.
9. van der Valk, P., van Kalken, C. K., Ketelaars, H., Broxterman, H. J., Scheffer, G., Kuiper, C. M., Tsuruo, T., Lankelma, J., Meijer, C. J. L. M., Pinedo, H. M., and Scheper, R. J. Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule. Ann. Oncol., 1: 56-64, 1990.
10. Cordon-Cardo, C., O'Brien, J. P., Boccia, J., Casals, D., Bertino, J. R., and Melamed, M. R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem., 38: 1277-1287, 1990.
11. Milroy, R., Plumb, J. A., Batstone, P., Maclay, A., Wishart, G. C., Hay, F. G., Candlish, W., Adamson, R., Khan, M. Z., Banham, S., and Kaye, S. B. Lack of expression of P-glycoprotein in 7 small cell lung cancer cell lines established both from untreated and from treated patients. Anticancer Res., 12: 193-200, 1992.
12. Weinstein, R. S., Grogan, T. M., Kuszak, J. R., Jakate, S. M., Kluskens, L. F., and Coon, J. S. Multidrug resistance gene product (P-glycoprotein) in normal tissue and tumors. In: Anonymous Advances in Pathology and Laboratory Medicine, pp. 207-234. St. Louis: Mosby, Inc. 1991.
13. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., and Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Washington DC), 258: 1650-1654, 1992.
14. Narasaki, F., Matsuo, I., Ikuno, N., Fukuda, M., Soda, H., and Oka, M. Multidrug resistance-associated protein (MRP) gene expression in human lung cancer. Anticancer Res., 16: 2079-2082, 1996.
15. Thomas, G. A., Barrand, M. A., Stewart, S., Rabbitts, P. H., Williams, E. D., and Twentyman, P. R. Expression of the multidrug resistance associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridisation. Eur. J. Cancer, 30A: 1705-1709, 1994.
16. Chuman, Y., Sumizawa, T., Takebayashi, Y., Niwa, K., Yamada, K., Haraguchi, M., Furukawa, T., Akiyama, S., and Aikou, T. Expression of the multidrug-resistance-associated protein (MRP) gene in human colorectal, gastric and non-small-cell lung carcinomas. Int. J. Cancer, 66: 274-279, 1996.
17. Savaraj, N., Wu, C. J., Xu, R., Feun, L. G., Lampidis, T. J., Tapiero, H., and Kuo, M. T. Quantitative multidrug resistance associated protein (MRP) gene expression by competitive reverse-transcriptase polymerase chain reaction (RT-PCR). Cell. Pharmacol., 4: 1997.
18. Ota, E., Abe, Y., Oshika, Y., Ozeki, Y., Iwasaki, M., Inoue, H., Yamazaki, H., Ueyama, Y., Takagi, K., Ogata, T., Tamaoki, N., and Nakamura, M. Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. Br. J. Cancer, 72: 550-554, 1995.
19. Zaman, G. J. R., Versantvoort, C. H. M., Smit, J. J. M., Eijdems, E. W. H. M., de Haas, M., Smith, A. J., Broxterman, H. J., Mulder, N. H., de Vries, E. G. E., Baas, F., and Borst, P. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res., 53: 1747-1750, 1993.
20. Nooter, K., Bosman, F. T., Burger, H., van Wingerden, K. E., Flens, M. J., Scheper, R. J., Oostrum, R. G., Boersma, A. W. M., van der Gaast, A., and Stoter, G. Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Ann. Oncol., 7: 75-81, 1996.
21. Giaccone, G., van Ark-Otte, J., Rubio, G. J., Gazdar, A. F., Broxterman, H. J., Dingemans, A-M., C., Flens, M. J., Scheper, R. J., and Pinedo, H. M. MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lung. Int. J. Cancer, 66: 760-767, 1996.
22. Sugawara, I., Akiyama, S., Scheper, R. J., and Itoyama, S. Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP. Cancer Lett., 112: 23-31, 1997.
23. Barrand, M. A., Heppell-Parton, A. C., Wright, K. A., Rabbitts, P. H., and Twentyman, P. R. A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. J. Natl. Cancer Inst., 86: 110-117, 1994.
24. r 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res., 54: 5788-5792, 1994.
25. Hipfner, D. R., Almquist, K. C., Stride, B. D., Deeley, R. G., and Cole, S. P. C. Location of a protease-hypersensitive region in the Multidrug Resistance Protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1. Cancer Res., 56: 3307-3314, 1996.
26. Almquist, K. C., Loe, D. W., Hipfner, D. R., Mackie, J. E., Cole, S. P. C., and Deeley, R. G. Characterization of the 190 kDa multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells. Cancer Res., 55: 102-110, 1995.
27. Cole, S. P. C., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., and Deeley, R. G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54: 5902-5910, 1994.
28. Sobin, L. H., and Wittekind, C. H. (eds.). UICC TNM Classification of Malignant Tumors. New York: Wiley-Liss, 1997.
29. Kaplan, E., and Meier, P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
30. Bonomi, P. Non-small cell lung cancer chemotherapy. In: H. I. Pass, J. B. Mitchell, D. H. Johnson, and A. T. Turrisi (eds.), Lung Cancer: Principles and Practice, pp. 811-823. Philadelphia: Lippincott-Raven, 1996.
31. McVie, J. G. Non-small cell lung cancer: meta-analysis of efficacy of chemotherapy. Semin. Oncol., 23: 12-14, 1996.
32. Norton, J. A., Levin, B., and Jensen, R. T. Cancer of the endocrine system. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles and Practice of Oncology, pp. 1333-1435, Philadelphia: J. B. Lippincott Co., 1993.
33. DeVore, R. F., III, and Johnson, D. H. Chemotherapy of small cell lung cancer. In: H. I. Pass, J. B. Mitchell, D. H. Johnson, and A. T. Turrisi (eds.), Lung Cancer: Principles and Practice, pp. 825-835. Philadelphia: Lippincott-Raven, 1996.
34. Evers, R., Zaman, G. J. R., van Deemster, L., Jansen, H., Calafat, J., Oomen, L. C. J. M., Oude Elferink, R. P. J., Borst, P., and Schinkel, A. H. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J. Clin. Invest., 97: 1211-1218, 1996.
35. Flens, M. J., Zaman, G. J. R., van der Valk, P., Izquierdo, M. A., Schroeijers, A. B., Scheffer, G. L., van der Groep, P., de Haas, M., Meijer, C. J. L. M., and Scheper, R. J. Tissue distribution of the multidrug resistance-associated protein. Am. J. Pathol., 148: 1237-1247, 1996.
36. 4 and structurally related conjugates. J. Biol. Chem., 269: 27807-27810, 1994.
37. Muller, M., Meijer, C., Zaman, G. J., Borst, P., Scheper, R. J., Mulder, N. H., de Vries, E. G., and Jansen, P. L. Overexpression of the gene encoding multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA, 91: 13033-13037, 1994.
38. 4 and chemotherapeutic agents in membrane vesicles: demonstration of glutathione-dependent vincristine transport. J. Biol. Chem., 271: 9675-9682, 1996.
39. Wijnholds, J., Evers, R., Van Leusden, M. R., Mol, C. A. A. M., Zaman, G. J. R., Mayer, U., Beijnen, J. H., van der Valk, M., Krimpenfort, P., and Borst, P. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat. Med., 3: 1275-1279, 1997.
40. Leier, I., Jedlitschky, G., Buchholz, U., Center, M., Cole, S. P. C., Deeley, R. G., and Keppler, D. ATP-dependent glutathione disulfide transport mediated by the MRP gene-encoded conjugate export pump. Biochem. J., 314: 433-437, 1996.
41. 1 and its glutathione conjugates by the product of the MRP gene. Mol. Pharmacol., 57: 1034-1041, 1997.
42. Mason, R. J., and Shannon, J. M. Alveolar type II cells in the lung. In: R. G. Crystal, J. B. West, E. R. Weibel, and P. J. Barnes (eds.), The Lung: Scientific Foundations, pp. 543-555. Philadelphia: Lippincott-Raven, 1977.
43. Tsutahara, S., Shijubo, N., Hirasawa, M., Honda, Y., Satoh, M., Kuroki, T., and Akino, T. Lung adenocarcinoma with type II pneumocyte characteristics. Eur. Respir. J., 6: 135-137, 1993.
44. Ten Have-Opbroek, A. A., Benfield, J. R., van Krieken, J. H., and Dijkman, J. H. The alveolar type II cell is a pluripotential stem cell in the genesis of human adenocarcinomas and squamous cell carcinomas. Histol. Histopathol., 12: 319-336, 1997.